The projects of 17 Biosciences Area scientists and engineers received funding through the FY22 Laboratory Directed Research and Development (LDRD) program.
A team of UC Berkeley and Berkeley Lab researchers used X-ray crystallography performed at the Advanced Light Source (ALS) to determine the atomic structure of ORF8, a protein secreted by the SARS-CoV-2 virus that is thought to help the pathogen evade and dampen response from human immune cells.
For the past several months, teams of bioscientists have utilized Berkeley Lab’s world-class research facilities to contribute to the national response to COVID-19, resulting in a wide range of promising research. Four videos showcase researcher contributions from across the Biosciences Area, which aim to help address some of the many scientific challenges posed by the pandemic.
Data gathered at Berkeley Lab’s Advanced Light Source (ALS) by an international team of researchers indicate that antibodies derived from SARS survivors could potently block entry of SARS-CoV-2 and other closely related coronaviruses into host cells. Such antibodies could be used as a preventative treatment or as a post-exposure therapy.
Corie Ralston and Marc Allaire, both staff scientists, have been promoted to new leadership positions. Ralston has assumed the position of Facility Director for the Biological Nanostructures Facility at the Molecular Foundry. Allaire has been appointed Head of the Molecular Biophysics and Integrated Bioimaging (MBIB) Division’s Berkeley Center for Structural Biology (BCSB). The BCSB manages six macromolecular crystallography beamlines at the Advanced Light Source (ALS).